Deal Snapshot
ILLUMINA TO ACQUIRE PACIFIC BIOSCIENCES IN CASH DEAL WORTH USD 1.2BN
Thursday 08 November 2018

California, US-based Illumina, Inc. (NASDAQ: ILMN) has agreed to acquire California-based Pacific Biosciences (NASDAQ: PACB) at a price of USD 8.0 per Pacific Biosciences share in an all-cash transaction, the company said.
This price represents a premium of 71% to Pacific Biosciences' 30 trading day volume weighted average share price as of the market close on October 31st, 2018, and a total enterprise value of approximately USD 1.2bn on a fully diluted basis.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 08/11/2018
Target: Pacific Biosciences
Country: USA
Deal Size: 1.2bn (USD)
Sector: Biotechnology
Type: Corporate acquisition
Financing: Cash
Status: Agreed
Vendor:
Buyer: Illumina, Inc
Comment:


Options